COX/5-LO-IN-2
COX/5-LO-IN-2 is a COX2, EGFR, COX1, 5-LOX, BRAF and FAK inhibitor with IC50 of 1.22 μM, 2.5 μM, 2.95 μM, 4.65 μM, 7.4 μM, 12.2 μM, respectively. COX/5-LO-IN-2 induces cell growth arrest at G2/M phase. COX/5-LO-IN-2 triggers apoptotic activity by up-regulating proapoptotic proteins p53, Bax, and caspase-7 and down-regulating anti-apoptotic protein Bcl-2. COX/5-LO-IN-2 can be used for the research of breast cancer.
For research use only. We do not sell to patients.
- Formula: C24H19N5O4S
- Molecular Weight:473.50
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
COX-2 1.22 μM (IC50) |
EGFR 2.5 μM (IC50) |
COX-1 2.95 μM (IC50) |
15-LOX 4.65 μM (IC50) |
Braf 7.4 μM (IC50) |
FAK 12.2 μM (IC50) |
Caspase-7 |
Bcl-2 |
Bax |
COX/5-LO-IN-2 (AS-14) (48 h) potently inhibits proliferation of PaCa-2, A-549, MCF-7, PC-3, and HT-29 human cancer cell lines with IC50 values ranging from 6.92 μM to 16.02 μM[1].
COX/5-LO-IN-2 inhibits recombinant human FAK, EGFR enzyme and BRAFV600E kinase with IC50 values of 12.2 μM, 2.5 μM, and 7.4 μM, respectively[1].
COX/5-LO-IN-2 induces G2/M phase cell cycle arrest in MCF-7 breast cancer cells at its IC50 dose of 10.27 μM[1].
COX/5-LO-IN-2 significantly induces apoptosis in MCF-7 breast cancer cells[1].
COX/5-LO-IN-2 up-regulates proapoptotic p53, Bax, and caspase-7 and down-regulates anti-apoptotic Bcl-2 in MCF-7 breast cancer cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
Molecular Weight 473.50
-
Formula C24H19N5O4S
-
SMILES
O=S(C1=CC=C(N2N=C(C3=NN=C(C4=CC=C(OC)C=C4)O3)C=C2C5=CC=CC=C5)C=C1)(N)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)